News Centermore
-
Athenex Presents Interim Data from Oral Paclitaxel Phase II Study in Cutaneous Angiosarcoma at ASCO20 Virtual Scientific Program
Jun 02, 2020
-
Hanmi ‘Gugu Tab.’ is soon to be launched in Japan market. Marketing and Sales for the BPH treatment will be by Sandoz Japan
Feb 28, 2020
-
Hanmi’s anti-NASH drug candidate set to become ‘game changer’ in global pharmaceutical market
Feb 28, 2020
-
[38th J.P. Morgan Healthcare Conference] “Hanmi, ready to lead global pharmaceutical market with innovative R&D pipeline”
Jan 16, 2020
![[38th J.P. Morgan Healthcare Conference] “Hanmi, ready to lead global pharmaceutical market with innovative R&D pipeline”](http://www.hanmi.co.kr/upfile/ces/information/INFORMATION_ENGLISH_NEWS/90118167/905e92ed-3c42-4852-93d4-4afff83ab530.jpg)
-
RAPT Announces Collaboration to Develop and Commercialize FLX475 WIth HANMI
Dec 09, 2019
AMOSARTAN TAB.5/50mg
Esomezol cap.
PalPal tab.
Pidogul tab.
Fluterol inhalation powder
Hyalrheuma Inj.
Triaxone inj.
Muco Gard